KT-253
A Phase 1, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Intravenously Administered KT-253 in Adult Patients With High Grade Myeloid Malignancies and Acute Lymphocytic Leukemia, Lymphoma and Advanced Solid Tumors
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sort by
HonorHealth Research and Innovation Institute
Scottsdale, AZ
- Accepting patients
Center of Excellence
Dana-Farber Cancer Institute
Boston, MA
- Accepting patients
Henry Ford Hospital
Detroit, MI
- Accepting patients
Montefiore Medical Center (Moses Campus)
The Bronx, NY
- Accepting patients
OU Health Stephenson Cancer Center
Oklahoma City, OK
- Accepting patients
Mary Crowley Cancer Research
Dallas, TX
- Accepting patients
Center of Excellence
- Accepting patients
- Accepting patients
- Accepting patients
Center of Excellence
The University of Texas Southwestern Medical Center
Harold C. Simmons Comprehensive Cancer Center
Dallas, TX
- Accepting patients
506 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.